We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ABBOTT UNIT WARNED FOR THRONG OF QSR VIOLATIONS
ABBOTT UNIT WARNED FOR THRONG OF QSR VIOLATIONS
May 7, 2004
The FDA has issued a warning letter to Abbott Laboratories following a pair of facility inspections that revealed serious quality system regulation (QSR) violations within its hospital products division, which now operates under the Hospira name.